Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001477932-25-002493
Filing Date
2025-04-07
Accepted
2025-04-07 13:57:42
Documents
5
Period of Report
2025-04-07

Document Format Files

Seq Description Document Type Size
1 FORM 6-K betrf_6k.htm 6-K 11093
2 MARCH 14, 2025 MATERIAL CHANGE REPORT betrf_ex991.htm EX-99.1 17281
3 APRIL 7, 2025 MATERIAL CHANGE REPORT betrf_ex992.htm EX-99.2 31092
4 betrf_ex992img2.jpg GRAPHIC 3926
5 betrf_ex991img1.jpg GRAPHIC 3915
  Complete submission text file 0001477932-25-002493.txt   71755
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 438-884-8841
BetterLife Pharma Inc. (Filer) CIK: 0001464165 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0131
Type: 6-K | Act: 34 | File No.: 333-161157 | Film No.: 25817499
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)